ES8703140A1 - Pyridoxine dextran sulphate prepn. - Google Patents

Pyridoxine dextran sulphate prepn.

Info

Publication number
ES8703140A1
ES8703140A1 ES550021A ES550021A ES8703140A1 ES 8703140 A1 ES8703140 A1 ES 8703140A1 ES 550021 A ES550021 A ES 550021A ES 550021 A ES550021 A ES 550021A ES 8703140 A1 ES8703140 A1 ES 8703140A1
Authority
ES
Spain
Prior art keywords
pyridoxine
prepn
formula
dextran sulphate
sulphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550021A
Other languages
Spanish (es)
Other versions
ES550021A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES550021A priority Critical patent/ES8703140A1/en
Publication of ES8703140A1 publication Critical patent/ES8703140A1/en
Publication of ES550021A0 publication Critical patent/ES550021A0/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pyridoxine dextrane sulphate of formula (I), for prevention and treatment of kidney stones is made by reacting pyridoxine for formula (V) in aq. soln. with sodium dextrane sulphate of formula (III) which has previously passed through Lewartite S-100 resin in protonic form. The final pH is kept at pH 3 approx. and the prod. separated by lyophilising as a yellowish-white powder with pyridoxine content 51-52% which decomposes at 220 deg.C.
ES550021A 1985-12-17 1985-12-17 Pyridoxine dextran sulphate prepn. Expired ES8703140A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES550021A ES8703140A1 (en) 1985-12-17 1985-12-17 Pyridoxine dextran sulphate prepn.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES550021A ES8703140A1 (en) 1985-12-17 1985-12-17 Pyridoxine dextran sulphate prepn.

Publications (2)

Publication Number Publication Date
ES8703140A1 true ES8703140A1 (en) 1987-02-16
ES550021A0 ES550021A0 (en) 1987-02-16

Family

ID=8490458

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550021A Expired ES8703140A1 (en) 1985-12-17 1985-12-17 Pyridoxine dextran sulphate prepn.

Country Status (1)

Country Link
ES (1) ES8703140A1 (en)

Also Published As

Publication number Publication date
ES550021A0 (en) 1987-02-16

Similar Documents

Publication Publication Date Title
EP0268463A3 (en) Zinc based ceramics
AU591319B2 (en) Preparation of antiperspirants
DE3687145D1 (en) INORGANIC MINERAL COMPOSITION.
EP0254413A3 (en) Silver-ionic water and its uses
NZ228632A (en) Topical otopathic preparations containing ofloxacin
GB2162849B (en) Treatment of aqueous soybean protein to add calcium
EP0285278A3 (en) Method of treating anxiety with tetrahydrobenzûc,d¨indole-6-carboxamides
CS274732B2 (en) Method of rhodium recovery
DE3462852D1 (en) Medicament preparation for external use comprising adenosin for the treatment of herpes
JPS5781411A (en) Medicinal composition having antiviral action
ES8703140A1 (en) Pyridoxine dextran sulphate prepn.
EP0444000A3 (en) Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
HUT63565A (en) Process for producing curqtive mixture consisting of glutathione and anthocyan compounds
EP0315118A3 (en) Dna coding for endothelin and use thereof
PT87393A (en) PROCESS FOR THE PREPARATION OF IMPROVED HYDROULIC CEMENT
ZA905932B (en) 14,17alpha-etheno-and-ethanoestratrienes,processes for the preparation of these compounds,as well as their use for the production of medicinal agents
GR852408B (en)
IL62988A0 (en) Germanium compounds,a process for the preparation thereof,a process for the preparation of a medicine using such a germanium compound for the treatment of cancer,as well as the shaped medicine thus formed and obtained
DE3570436D1 (en) Process for the preparation of hydrogeno or halogenosilanes
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
SE8704832L (en) Prepn. for dissolving caries - comprises nitrogen-contg. cpds. and sodium hypochlorite
EP0151245A3 (en) Soporific comprising lorazepam
Bindslev Artificial intelligence in building
JPS6431798A (en) T-quinine derivative
NZ236206A (en) Preparation of 2'-methyl-4'-methylenespiro(androstadiene-17,5'(4'h)-oxazol)-3-one derivatives from pregn-5-en-20-ylideneacetamide derivatives by treatment with vilsmeier reagent or acid